trending Market Intelligence /marketintelligence/en/news-insights/trending/ta-PAzAmuK4-gzcCwBozOg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Takeda's $62B acquisition of Shire gets approval of Jersey court

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Takeda's $62B acquisition of Shire gets approval of Jersey court

Takeda Pharmaceutical Co. Ltd. said the Royal Court of Jersey approved its $62 billion acquisition of Irish drugmaker Shire PLC.

The Japanese drugmaker, which finally managed to claim Shire in its fifth takeover attempt in May 2018, said the acquisition is expected to close Jan. 8.

The deal has already been approved by the shareholders of both companies, the EU and the Japan Fair Trade Commission.